Active Ingredient(s): Cisatracurium
FDA Approved: * December 15, 1995
Pharm Company: * ABBOTT
Category: Muscle Relaxer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nimbex Overview

Cisatracurium besilate (INN; cisatracurium besylate (USAN); formerly recognized as 51W89;[1] trade name Nimbex) is a bisbenzyltetrahydroisoquinolinium that has effect as a neuromuscular-blocking drug non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It shows intermediate duration of action. Cisatracurium is one of the ten isome...

Read more Nimbex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nimbex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 10mg/ml, 2mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nimbex: (3 results)

Sorted by National Drug Code
  • 0074-4378 Nimbex 2 mg/ml Intravenous Injection by Abbvie Inc.
  • 0074-4380 Nimbex 2 mg/ml Intravenous Injection by Abbvie Inc.
  • 0074-4382 Nimbex 10 mg/ml Intravenous Injection by Abbvie Inc.

Other drugs which contain Cisatracurium or a similar ingredient: (1 result)